Preventive
PrivateLast Round
Seed
Oct 30, 2025
Total Funding Raised
$30M
Company Overview
Preventive is a biotechnology company that develops prenatal gene-editing technologies intended for the prevention of severe genetic conditions before birth.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
prenatal gene editinggermline editingCRISPRprime editingembryo editinggenetic disease preventionpreclinical researchbiotechnology researchgene therapyreproductive medicineprecision medicinepublic benefit corporationPBCdesigner babies
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Preventive Comparables
Compare Preventive with similar companies based on industry and business-model similarity.
Preventive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 30, 2025 |
Preventive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SciFounders | Seed |
Preventive Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Preventive's valuation, stock price, and market status.
Firmographic Details
HeadquartersSouth San Francisco, California
Year Founded2025
Last FundingOct 30, 2025